Meeting the Challenges in Veterinary Pharmacovigilance Regulations
The Veterinary Medicinal Products (VMP) environment is growing and increasing its regulatory requirements for pharmacovigilance. Global requirements for safety surveillance and pharmacovigilance include the (EU) 2019/6, Commission Implementing Regulation (EU) 2021/1281, FDA CVM regulations, VMD UK: The Veterinary Medicines Regulations 2013 SI 2033, and other global regulations.
Your Partner in Veterinary Pharmacovigilance
As your global partner, our veterinary experts can assist sponsors, marketing authorization holders (MAHs), and applicants with their veterinary pharmacovigilance needs. Biologit can act as a virtual safety surveillance department for veterinary companies, supporting and maintaining their safety systems with a focus on animal, human and environmental safety, research and development, regulatory approval and post market surveillance.
Pharmacovigilance Systems for Veterinary Products
Scientific and Medical Literature Monitoring
Quality Systems for Veterinary Medicinal Products
Veterinary QPPV (Qualified Person for Pharmacovigilance)
Project Planning and Training
Literature Monitoring for Veterinary Pharmacovigilance
Monitoring the scientific literature for adverse events is a critical component for active safety surveillance of post-market veterinary products and regulatory submissions.
The biologit's MLM-AI platform is a validated and compliant SaaS solution for veterinary companies, providing a flexible workflow, unified scientific database, and unique AI productivity to help ensure your products are compliant and all data is audit ready.